<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00234260</url>
  </required_header>
  <id_info>
    <org_study_id>U01HL075572</org_study_id>
    <nct_id>NCT00234260</nct_id>
  </id_info>
  <brief_title>Family Blood Pressure Program - GENOA (Genetic Epidemiology Network of Atherosclerosis)</brief_title>
  <official_title>Family Blood Pressure Program - GENOA (Genetic Epidemiology Network of Atherosclerosis)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The University of Texas Health Science Center, Houston</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Heart, Lung, and Blood Institute (NHLBI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>The University of Texas Health Science Center, Houston</source>
  <brief_summary>
    <textblock>
      GENOA, the Genetic Epidemiology Network of Arteriopathy, consists of a network of three field
      centers and biochemical and genetic core labs to study the common polymorphic genetic
      variations to determine individual differences in blood pressure and essential hypertension
      in 1,500 sibling pairs in three racial groups. Linkage analyses are performed using an
      extensive array of candidate genes and anonymous markers throughout the genome.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Each collaborating investigator is responsible for an essential element of the network: Eric
      Boerwinkle for genotyping and linkage analyses, Robert Ferrell for genotyping, Craig Hanis
      for recruiting Mexican-Americans, Richard Hutchinson for recruiting African-Americans, Sharon
      Kardia for cladistic and prediction analyses and data management, and Stephen Turner for
      recruiting Non-Hispanic whites and measuring physiologic variables. Between 1995 and 2000,
      the network carried out five specific aims to localize and characterize the genetic
      determinants of high blood pressure. Aim 1 used robust sibling pair linkage methods in 500
      hypertensive sibling pairs in each racial group (a total of 1,500 sibling pairs) to localize
      genes influencing interindividual differences in the occurrence of essential hypertension.
      Aims 2 and 3 took advantage of previously collected blood pressure and intermediate predictor
      trait data from 1,488 normotensive sibling pairs from the Rochester Family Heart Study to
      localize genes contributing to essential hypertension. The linkage analyses (Aims 1-3) used
      both an extensive array of candidate genes and a large number of anonymous markers throughout
      the genome. Aim 4 used multiple diallelic sequence polymorphisms and cladistic analyses
      within a linked gene to identify haplotypes for further DNA sequencing in order to identify
      candidate functional DNA sequence variation contributing to interindividual differences in BP
      levels and essential hypertension status. Aim 5 evaluated the ability of candidate functional
      DNA sequence variation to predict essential hypertension status in the three racial groups.

      The study was renewed in September 2000 to pursue two lines of investigation. The first is to
      identify and characterize genes contributing to atherosclerotic coronary heart disease using
      electron beam computed tomography (EBCT) to quantify coronary artery calcification as a
      measure of preclinical disease. Robust sibling-pair linkage methods will be used to determine
      whether any of the more than 375 highly polymorphic tandem repeat marker loci spanning the
      genome are linked to genes influencing EBCT measures of coronary artery calcification in at
      least 500 GENOA sibships from Rochester, Minnesota. Association analysis will be used to
      determine whether biallelic markers of DNA sequence variation in candidate genes identified
      by GENOA or others to influence blood pressure level or diagnostic category also influence
      EBCT measures of coronary artery calcification in at least 500 GENOA participants from
      Rochester, Minnesota. The second line of investigation extends analytical methods (linkage
      disequilibrium regression and combinatorial partitioning) to more finely localize positional
      candidate genes and loci, and to identify gene-gene and gene-environment interaction effects
      influencing the measured Family Blood Pressure Program and GENOA phenotypes.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <start_date>April 1995</start_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <condition>Arteriosclerosis</condition>
  <condition>Hypertension</condition>
  <condition>Heart Diseases</condition>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Jackson Mississippi - age 45-64, Hypertensive Rochester, Minnesota - &lt;60, Hypertensive
        Starr County, Texas - &lt;60, type II diabetes mellitus

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>64 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Eric Boerwinkle, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Human Genetics Center, The University of Texas at Houston Health Science Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Rochester Field Center</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Jackson Field Center</name>
      <address>
        <city>Jackson</city>
        <state>Mississippi</state>
        <zip>39216</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Starr County Field Center</name>
      <address>
        <city>Rio Grande City</city>
        <state>Texas</state>
        <zip>78588</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>FBPP Investigators. Multi-center genetic study of hypertension: The Family Blood Pressure Program (FBPP). Hypertension. 2002 Jan;39(1):3-9.</citation>
    <PMID>11799070</PMID>
  </reference>
  <results_reference>
    <citation>An P, Freedman BI, Hanis CL, Chen YD, Weder AB, Schork NJ, Boerwinkle E, Province MA, Hsiung CA, Wu X, Quertermous T, Rao DC. Genome-wide linkage scans for fasting glucose, insulin, and insulin resistance in the National Heart, Lung, and Blood Institute Family Blood Pressure Program: evidence of linkages to chromosome 7q36 and 19q13 from meta-analysis. Diabetes. 2005 Mar;54(3):909-14.</citation>
    <PMID>15734873</PMID>
  </results_reference>
  <results_reference>
    <citation>Daniels PR, Kardia SL, Hanis CL, Brown CA, Hutchinson R, Boerwinkle E, Turner ST; Genetic Epidemiology Network of Arteriopathy study. Familial aggregation of hypertension treatment and control in the Genetic Epidemiology Network of Arteriopathy (GENOA) study. Am J Med. 2004 May 15;116(10):676-81.</citation>
    <PMID>15121494</PMID>
  </results_reference>
  <results_reference>
    <citation>Kullo IJ, Bailey KR, Bielak LF, Sheedy PF 2nd, Klee GG, Kardia SL, Peyser PA, Boerwinkle E, Turner ST. Lack of association between lipoprotein(a) and coronary artery calcification in the Genetic Epidemiology Network of Arteriopathy (GENOA) study. Mayo Clin Proc. 2004 Oct;79(10):1258-63.</citation>
    <PMID>15473406</PMID>
  </results_reference>
  <results_reference>
    <citation>Kullo IJ, Bailey KR, Kardia SL, Mosley TH Jr, Boerwinkle E, Turner ST. Ethnic differences in peripheral arterial disease in the NHLBI Genetic Epidemiology Network of Arteriopathy (GENOA) study. Vasc Med. 2003 Nov;8(4):237-42.</citation>
    <PMID>15125483</PMID>
  </results_reference>
  <results_reference>
    <citation>Morrison AC, Cooper R, Hunt S, Lewis CE, Luke A, Mosley TH, Boerwinkle E. Genome scan for hypertension in nonobese African Americans: the National Heart, Lung, and Blood Institute Family Blood Pressure Program. Am J Hypertens. 2004 Sep;17(9):834-8.</citation>
    <PMID>15363828</PMID>
  </results_reference>
  <results_reference>
    <citation>O'Meara JG, Kardia SL, Armon JJ, Brown CA, Boerwinkle E, Turner ST. Ethnic and sex differences in the prevalence, treatment, and control of dyslipidemia among hypertensive adults in the GENOA study. Arch Intern Med. 2004 Jun 28;164(12):1313-8.</citation>
    <PMID>15226165</PMID>
  </results_reference>
  <results_reference>
    <citation>Turner ST, Jack CR, Fornage M, Mosley TH, Boerwinkle E, de Andrade M. Heritability of leukoaraiosis in hypertensive sibships. Hypertension. 2004 Feb;43(2):483-7. Epub 2004 Jan 12.</citation>
    <PMID>14718359</PMID>
  </results_reference>
  <results_reference>
    <citation>Province MA, Kardia SL, Ranade K, Rao DC, Thiel BA, Cooper RS, Risch N, Turner ST, Cox DR, Hunt SC, Weder AB, Boerwinkle E; National Heart, Lung and Blood Institute Family Blood Pressure Program. A meta-analysis of genome-wide linkage scans for hypertension: the National Heart, Lung and Blood Institute Family Blood Pressure Program. Am J Hypertens. 2003 Feb;16(2):144-7.</citation>
    <PMID>12559682</PMID>
  </results_reference>
  <results_reference>
    <citation>Wu X, Cooper RS, Borecki I, Hanis C, Bray M, Lewis CE, Zhu X, Kan D, Luke A, Curb D. A combined analysis of genomewide linkage scans for body mass index from the National Heart, Lung, and Blood Institute Family Blood Pressure Program. Am J Hum Genet. 2002 May;70(5):1247-56. Epub 2002 Mar 28.</citation>
    <PMID>11923912</PMID>
  </results_reference>
  <results_reference>
    <citation>Province MA, Boerwinkle E, Chakravarti A, Cooper R, Fornage M, Leppert M, Risch N, Ranade K. Lack of association of the angiotensinogen-6 polymorphism with blood pressure levels in the comprehensive NHLBI Family Blood Pressure Program. National Heart, Lung and Blood Institute. J Hypertens. 2000 Jul;18(7):867-76.</citation>
    <PMID>10930184</PMID>
  </results_reference>
  <results_reference>
    <citation>Morrison AC, Brown A, Kardia SL, Turner ST, Boerwinkle E; Genetic Epidemiology Network of Arteriopathy (GENOA) Study. Evaluating the context-dependent effect of family history of stroke in a genome scan for hypertension. Stroke. 2003 May;34(5):1170-5. Epub 2003 Apr 24.</citation>
    <PMID>12714704</PMID>
  </results_reference>
  <verification_date>October 2005</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 4, 2005</study_first_submitted>
  <study_first_submitted_qc>October 4, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 6, 2005</study_first_posted>
  <last_update_submitted>July 15, 2008</last_update_submitted>
  <last_update_submitted_qc>July 15, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 16, 2008</last_update_posted>
  <keyword>Genetics</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Atherosclerosis</mesh_term>
    <mesh_term>Arteriosclerosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

